🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kian‐Huat Lim

Washington University in St. Louis

ORCID: 0000-0002-2766-200X

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

2.7Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

Nature Communications(2021)10.1038/s41467-021-25177-3

Top 8%

2.7DataRank

Top 8%109 citations

Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl +94 more

Papers

Driven by 15 papers — median percentile 92. Top paper: “Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment”.

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

Nature Communications(2021)10.1038/s41467-021-25177-3

Top 8%

2.7DataRank

Top 8%109 citations

Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl +94 more

Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combination with standard chemotherapy for patients with advanced, inoperable pancreatic adenocarcinoma: a phase 1b observational study

Cancer & Metabolism(2023)10.1186/s40170-023-00306-2

N/A

0.947DataRank · unranked

30 citations

Kian‐Huat Lim, J. L. Volkman, Mina Abdiannia, Hannah Johnston, Zack Nigogosyan +13 more

Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer

Nature Communications(2024)10.1038/s41467-024-46811-w

N/A

0.524DataRank · unranked

32 citations

Peng Liu, Kuljeet Seehra, Sapana Bansod, Yali Chen, Kiran Zahra +22 more

Chemokine Receptor 2 Targeted PET/CT Imaging Distant Metastases in Pancreatic Ductal Adenocarcinoma

ACS Pharmacology & Translational Science(2023)10.1021/acsptsci.3c00303

N/A

0.165DataRank · unranked

2 citations

Lisa Detering, Gyu Seong Heo, Deborah Sultan, Hannah Luehmann, Lin Li +13 more

Induction of cancer neoantigens facilitates development of clinically relevant models for the study of pancreatic cancer immunobiology

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03463-x

N/A

0.165DataRank · unranked

2 citations

Michael Y. Chen, Felicia Zhang, Darren R. Cullinan, Lijin Li, C. Alston James +14 more

Divergent Roles for RalA and RalB in Malignant Growth of Human Pancreatic Carcinoma Cells

UNC Libraries(2021)10.17615/68xg-tf12

N/A

0DataRank · unranked

0 citations

Paul M. Campbell, Kevin O’Hayer, Christopher M. Counter, Kian‐Huat Lim, Stacey J. Adam +2 more

IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal Adenocarcinoma

Gastroenterology(2022)10.1053/j.gastro.2022.02.035

N/A

0DataRank · unranked

63 citations

Daoxiang Zhang, Paarth B. Dodhiawala, Varintra E. Lander, Xiuting Liu, Liang‐I Kang +8 more

High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survival

npj Precision Oncology(2023)10.1038/s41698-023-00455-z

N/A

0DataRank · unranked

36 citations

Prathamesh Chati, Abul Usmani, Ian H. Sloan, Bradley A. Krasnick, Ramandeep K. Babbra +25 more

Data from Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma

(2023)10.1158/1078-0432.c.6525797

N/A

0DataRank · unranked

0 citations

Lin Li, Hongmei Jiang, Brett L. Knolhoff, A. Craig Lockhart, Andrea Wang‐Gillam +4 more

Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer

Signal Transduction and Targeted Therapy(2020)10.1038/s41392-020-00341-1

N/A

0DataRank · unranked

197 citations

Kian‐Huat Lim, Ashenafi Bulle

The TRIM4 E3 ubiquitin ligase degrades TPL2 and is modulated by oncogenic KRAS

Cell Reports(2024)10.1016/j.celrep.2024.114667

N/A

0DataRank · unranked

3 citations

Paarth B. Dodhiawala, Yutong Geng, Ashenafi Bulle, Peng Liu, Lin Li +6 more

The clonal evolution of metastatic colorectal cancer

Science Advances(2020)10.1126/sciadv.aay9691

N/A

0DataRank · unranked

78 citations

Bradley A. Krasnick, Brian S. White, Julie Grossman, Matthew S. Strand, Jin Zhang +20 more

TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations

Journal of Clinical Investigation(2020)10.1172/jci137660

N/A

0DataRank · unranked

33 citations

Namrata Khurana, Daoxiang Zhang, Yi Cheng, Lin Li, Qing Wei +6 more

RALA and RALBP1 regulate mitochondrial fission at mitosis

UNC Libraries(2020)10.17615/sdq3-ft28

N/A

0DataRank · unranked

0 citations

Nicole L. K. Pershing, David F. Kashatus, Donita C. Brady, Christopher M. Counter, Kian‐Huat Lim +1 more

Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities

Cancers(2021)10.3390/cancers13215481

N/A

0DataRank · unranked

24 citations

Paarth B. Dodhiawala, Kian‐Huat Lim, Sapana Bansod